M&A Deal Summary

The Spectranetics Acquires AngioScore

On May 27, 2014, The Spectranetics acquired medical products company AngioScore from Telegraph Hill Partners for 230M USD

Acquisition Highlights
  • This is The Spectranetics’ 2nd transaction in the Medical Products sector.
  • This is The Spectranetics’ largest (disclosed) transaction.
  • This is The Spectranetics’ 1st transaction in the United States.
  • This is The Spectranetics’ 1st transaction in California.

M&A Deal Summary
Date 2014-05-27
Target AngioScore
Sector Medical Products
Buyer(s) The Spectranetics
Sellers(s) Telegraph Hill Partners
Deal Type Add-on Acquisition
Deal Value 230M USD

Target

AngioScore

Fremont, California, United States
AngioScore, Inc. is a developer, manufacturer and marketer of cardiovascular, specialty balloons endovascular therapy.

Search 201,839 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

The Spectranetics

Colorado Springs, Colorado, United States
Category Company
Founded 1984
Sector Medical Products
Employees892
Revenue 246M USD (2015)
DESCRIPTION
Entrance to Spectranetics' corporate headquarters in Colorado Springs, Colorado.
Entrance to Spectranetics' corporate headquarters in Colorado Springs, Colorado.

The Spectranetics Corp. is a medical device company. Spectranetics developes, manufactures, and distributes of single-use medical devices used in minimally invasive procedures within the cardiovascular system. Spectranetics Corp. was formed in 1984 and is headquartered in Colorado Springs, Colorado.

DEAL STATS #
Overall 2 of 3
Sector (Medical Products) 2 of 3
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 2
Year (2014) 1 of 2
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-07 Upstream Peripheral Technologies

Israel

Upstream Peripheral Technologies Ltd. is a developer of medical products.

Buy $6M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-11-02 Covidien - Stellarex Drug Coated Balloon

United States

Buy $30M

Seller(S) 1

SELLER

Telegraph Hill Partners

San Francisco, California, United States

Investor Investor Investor Investor Investor

Category Venture Capital Firm
Founded 2001
Size Middle-Market
Type Sector Focused
DESCRIPTION

Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.

DEAL STATS #
Overall 16 of 29
Sector (Medical Products) 9 of 14
Type (Add-on Acquisition) 13 of 24
State (California) 11 of 18
Country (United States) 16 of 28
Year (2014) 1 of 3
Size (of disclosed) 5 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-19 Estech

San Ramon, California, United States

Estech is a developer and marketer of surgical ablation devices that enable physicians to perform a variety of traditional and minimally invasive procedures. Estech is based in San Ramon, California.

Sell $34M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-05-30 Agena Bioscience

San Diego, California, United States

Agena Bioscience is a life science and clinical diagnostics company that offers the MassARRAY® System. The system is a highly sensitive, quantitative method for nucleic acid detection via MALDI-TOF mass spectrometry for high-throughput genotyping and mutation profiling for cancer and other disease research, companion diagnostics, pharmacogenomics, epigenetics, clinical genetics, ag-bio genetics, and biobanking molecular sample identification. Agena Bioscience was established in 2014 and is based in San Diego, California.

Buy -
Mergr

Product

Company

Legal